Clinical Trial Update: Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of venglustat with Cerezyme in adults with Gaucher disease type 3, including a venglustat monotherapy extension; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• CEREZYME (imiglucerase)
• Venglustat (venglustat)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Gaucher Disease Type 1, Gaucher Disease Type 3 | Phase 2 | Status: ACTIVE_NOT_RECRUITING